The orphan nuclear receptor TLX is a master regulator of postnatal neural stem cell (NSC) self-renewal and neurogenesis; however, it remains unclear how TLX expression is precisely regulated in these tissue-specific stem cells. Here, we show that a highly conserved cis-element within the Tlx locus functions to drive gene expression in NSCs. We demonstrate that the transcription factors SOX2 and MYT1 specifically interact with this genomic element to directly regulate Tlx enhancer activity in vivo. Knockdown experiments further reveal that SOX2 dominantly controls endogenous expression of TLX, whereas MYT1 only plays a modulatory role. Importantly, TLX is essential for SOX2-mediated in vivo reprogramming of astrocytes and itself is also sufficient to induce neurogenesis in the adult striatum. Together, these findings unveil functional genetic interactions among transcription factors that are critical to NSCs and in vivo cell reprogramming.
INTRODUCTION
Neural stem cells (NSCs) are self-renewing, multipotent progenitors with critical roles in the development of a functional nervous system and neuron differentiation (AlvarezBuylla and Temple, 1998; McKay, 1997; Weiss and van der Kooy, 1998) . Mounting evidence indicates that adult NSCs, which normally reside in the subgranular zone (SGZ) of the dentate gyrus (DG) and the subventricular zone (SVZ) of the lateral ventricle (LV), are essential for maintaining adult brain homeostasis (Gage, 2000; McKay, 1997; Rao, 1999) . NSCs in these niches are critical to brain plasticity, but the molecular mechanisms governing these processes have yet to be elucidated.
The orphan nuclear receptor subfamily 2 group E member 1 (NR2E1), commonly known as TLX, has been identified as a fundamental regulator of adult NSCs and neurogenesis (Liu et al., 2008; Niu et al., 2011; Shi et al., 2004; Wang et al., 2013; Zhang et al., 2008) . While TLX expression is observed in the forebrain and retina during early development, it becomes confined to NSCs of the DG and SVZ where neurogenesis continues into adulthood (Hollemann et al., 1998; Kitambi and Hauptmann, 2007; Monaghan et al., 1995) . Even though no obvious defects are found in the brains of Tlx null mice during early development, mature mice exhibit limbic defects, retinopathies, reduced copulation, and progressively violent behavior (Islam and Zhang, 2015; Monaghan et al., 1997; Yu et al., 2000) . The primary function of this key transcriptional regulator is to prevent the precocious differentiation of NSCs in the developing and adult brain (Li et al., 2008; Niu et al., 2011; Roy et al., 2004; Shi et al., 2004) . TLX controls the expression of a broad network of genes to maintain NSC pools in an undifferentiated, self-renewing state (Niu et al., 2011; Shi et al., 2004 Shi et al., , 2008 Zhang et al., 2008) . TLX functions through the transcriptional suppression of target genes in association with other transcriptional corepressors like lysine-specific histone demethylase 1 (LSD1) (Sun et al., 2007 (Sun et al., , 2011 Yokoyama et al., 2008) . Histone deacetylases (HDACs) are also recruited by TLX to target genes, which restrain transcription and, in turn, regulate NSC proliferation (Sun et al., 2007) . While the essential roles of TLX in NSC self-renewal and differentiation have been well established, relatively little is known about the molecular mechanisms that govern the spatiotemporal expression of this critical factor in the developing and adult brain (Li et al., 2008; Roy et al., 2004; Shi et al., 2004 Shi et al., , 2008 .
To identify novel regulatory elements that will provide insight into this mechanism, we probed highly conserved sequences of the Tlx locus using in vitro screening and in vivo transgenic assays. Here, we have identified a single short DNA element bound by the transcription factors, sex determining region-box 2 (SOX2) and myelin transcription factor 1/neural zinc finger 2 (MYT1), which directly regulate Tlx expression in postnatal NSCs. We further unveiled that TLX mediates SOX2-dependent in vivo reprogramming of astrocytes in the adult mouse brain.
RESULTS

Identification of NSC-Specific Enhancers within the Tlx Locus
A cross-species comparison of genomic DNA sequences revealed multiple highly conserved regions within the Tlx locus ( Figure 1A ). To examine whether any of these conserved elements promote Tlx expression, we screened seven conserved DNA regions in cultured adult NSCs by linking the indicated genomic sequences to a b-galactosidase (b-gal) reporter. This systematic in vitro analysis revealed that five of these seven conserved regions were sufficient to drive b-gal reporter expression in NSCs, but not in other non-NSC lines, such as NIH 3T3, COS7, or HELA ( Figure S1 ; data not shown). Next, a conventional in vivo transgenic analysis showed that only two of these regions, region 4 and region 5, were sufficient to drive reporter expression in the embryonic day (E) 12.5-13.5 forebrain in a pattern that resembles endogenous Tlx ( Figures  1A and 1B) (Zhang et al., 2006) . The first putative enhancer region (Enh1) we identified was a 3.3-kb fragment located 8 kb upstream of the Tlx transcription start site within region 4 ( Figure 1A ). The second putative enhancer region (Enh2) was a 4.2-kb fragment located within the first Tlx intron, a subsection of region 5 ( Figure 1A ). Both of these putative enhancers were capable of driving reporter expression in the developing forebrain and retina ( Figure 1B) . When analyzed at postnatal day (P) 28, signal intensity for the b-gal reporter remained robust for Enh1 but tapered for Enh2. Further, Enh2-driven b-gal expression was dramatically reduced in adult neurogenic regions as compared to the Enh1-driven reporter (Figures 1C and Figure S1 . 1D). Therefore, we opted to narrow the focus of our investigations to the enhancer activity of Enh1.
A second screen of smaller Enh1-derived DNA fragments uncovered a 582-nt region (Enh1.1) sufficient to drive reporter expression in cultured adult NSCs and transgenic E13.5 embryos ( Figures 1E and 1F) . Interestingly, Enh1.1-driven reporter expression is robustly detected throughout the developing CNS, indicating that neighboring elements of the full-length Enh1 region act to restrict Tlx expression to the forebrain and retina during early development.
Enh1.1.3 Enhancer Is Active in TLX + NSCs
To define the minimal functional region of Enh1 sufficient to drive Tlx expression, Enh1.1 was subdivided into six roughly 120-bp overlapping fragments and then cloned into a GFP reporter vector ( Figure 2A ; Table S1 ). Each clone was co-electroporated with a control plasmid expressing tdTomato under the constitutively active CAG promoter into the forebrains of P0 mice ( Figure 2B ). GFP reporter expression was evaluated 5 days later ( Figure 2C ). Strong reporter expression was observed for the Enh1.1 subregion Enh1.1.3, while Enh1.1.6 induced moderate reporter signal ( Figure 2C ). Interestingly, the Enh1.1.3 element falls within a highly conserved region of the Tlx locus ( Figure 2A ). To validate Enh1.1.3 as a bona fide Tlx enhancer, we analyzed the spatial expression pattern of this DNA element in the SVZ using a GFP reporter. An Enh1.1.3-GFP construct was electroporated into the LV of the P0 mouse forebrain, and reporter expression was evaluated 5 days later. Greater than 91% of Enh1.1.3-GFP + cells co-labeled with TLX, while only 63% of control CAG-GFP transduced cells were TLX + , indicating robust transcriptional activity of this enhancer in postnatal NSCs ( Figure 2D ).
Enh1.1.3 Activity Requires SOX2 Binding
We next aimed to identify potential trans-acting factor binding sites within the Enh1.1.3 enhancer. We used MatInspector to computationally identify 24 transcription factor binding sites, then narrowed our focus to four of these factors based on known molecular functions and spatiotemporal expression patterns (Cartharius et al., 2005) . We used site-directed mutagenesis to delete one or more binding sites for each of these transcription factors and generated five Enh1.1.3 mutant GFP reporter constructs, SOX2-BS1, SOX2-BS2, SOX2-BS1+BS2, MYT1, and Table S1 .
NFkB ( Figure 3A ). Forebrain tissue electroporated with the NFkB-binding site-deleted construct showed no significant change in GFP reporter expression, whereas a moderate reduction of reporter activity was observed for constructs with mutations of SOX2-BS1 and SOX2-BS2, respectively ( Figure 3B ). Interestingly, the combined deletion of both SOX2-binding sites (SOX2-BS1+BS2) greatly diminishes GFP expression, indicating these sites are redundant but required for Enh1.1.3 cis-regulatory activity ( Figure 3B ).
Unexpectedly, the deletion of these SOX2-binding sites from the full-length Enh1.1 Tlx regulatory element does not significantly alter enhancer activity (data not shown), suggesting additional redundancy among the five putative SOX2-binding sites within this larger enhancer region. (C) MYT1 directly binds to the identified enhancer. Antibody-induced supershift in electrophoresis mobility shift assays (EMSA) is shown in the boxed region. Normal IgG was used as controls for EMSA and chromatin immunoprecipitation (ChIP) assays (mean ± SEM; n = 3 independent experiments for control IgG and MYT1 antibody). (D) SOX2 directly binds to the identified enhancer. The boxed region shows antibody-induced supershift of the probe. Normal IgG was used as controls for EMSA and ChIP (mean ± SEM; n = 3 independent experiments for control IgG and SOX2 antibody). See also Table S2 . diminishes enhancer activity ( Figure 3B ). To confirm the sequence-specific binding of MYT1 to this predicted binding site, we performed an electrophoretic mobility shift assay (EMSA) ( Figure 3C ). A double-stranded DNA probe containing the MYT1-binding site within Enh1.1.3 showed a distinct shift when incubated with NSC nuclear extracts, indicating a sequence-specific DNA-protein interaction (indicated by arrows in Figure 3C) . Further, the addition of a MYT1-specific antibody induced a supershift not observed in the mock immunoglobulin G (IgG)-antibody-treated control (boxed region in Figure 3C ). As expected, mutation of the MYT1-binding site in this probe resulted in the loss of specific protein binding ( Figure 3C ). These in vitro data strongly support MYT1 interaction with the Enh1.1.3 Tlx enhancer.
To confirm SOX2 sequence-specific binding to the Enh1.1.3 enhancer element, we similarly performed EMSA with DNA probes specific to the Enh1.1.3 SOX2-binding region. These complementary probes exhibited a specific shift when incubated with NSC nuclear extracts and were distinctly supershifted when incubated with SOX2-specific antibody (boxed region in Figure 3D ). Moreover, mutation of the predicted SOX2-binding sites abolished this specific probe-SOX2 interaction (indicated by an arrow in Figure 3D ). These results confirm the in vitro binding of SOX2 within the Tlx cis-element Enh1.1.3.
To validate the in vivo binding of these factors to Enh1.1.3, we performed chromatin immunoprecipitation (ChIP) assays using early postnatal mouse forebrains and antibodies specific to SOX2 or MYT1. qPCR analysis for the EMSA-identified MYT1-binding site showed a greater than 3-fold enrichment in MYT1 ChIP DNA over a mock IgG control ( Figure 3C ; ChIP). Similarly, SOX2 binding was confirmed with greater than 12-fold ChIP enrichment over IgG ( Figure 3D ; ChIP).
MYT1 Modulates Tlx Enhancer Activity
To determine the role for MYT1 binding within the Enh1.1.3 Tlx enhancer element, we analyzed the effects of short hairpin RNA (shRNA)-mediated Myt1 knockdown on E1.1.3 enhancer activity in vivo. A shRNA screen in HEK293 cells identified a highly efficient Myt1-targeting shRNA (Myt1-shRNA1; Figure 4A ). Due to the lack of a suitable antibody for specific MYT1 immunohistochemical staining in the mouse forebrain, we co-electroporated Enh1.1-LacZ and Enh1.1.3-LacZ with Myt1-shRNA1 to determine whether MYT1 knockdown would significantly reduce reporter expression relative to a scrambled shRNA control. As shown in Figure 4B , MYT1 knockdown dramatically reduced the Enh1.1.3-driven b-gal expression but exhibited minimal effect on Enh1.1-driven reporter expression ( Figure 4B Table S3 .
observed after Myt1 knockdown ( Figures 4C and 4D) . Together, these results indicate that MYT1 controls the activity of a defined Tlx enhancer, but its activity is not a major driving force for the overall expression of endogenous Tlx.
SOX2 Controls Tlx Enhancer Activity and Endogenous Expression
To determine the role of SOX2 in the regulation of this enhancer, Enh1.1-GFP and Enh1.1.3-GFP were coelectroporated with two shRNAs targeting Sox2 mRNA into the P0 mouse forebrain and analyzed 5 days later ( Figure 5A ). A scrambled shRNA sequence and the coelectroporated CAG-tdTomato were used as controls. Sox2-shRNA1 and Sox2-shRNA2 significantly reduced both Enh1.1-and Enh1.1.3-driven GFP expression (Figures 5A-5C 5D and 5F). Importantly, the expression of endogenous TLX is also dramatically reduced due to the downregulation of SOX2 in these cells ( Figures 5E and 4F ). This suggests a dominant role for SOX2 in the control of TLX expression.
TLX Is Required for SOX2-Mediated In Vivo Reprogramming
We and others recently showed that SOX2 can in vivo reprogram reactive glia into neural progenitors and neurons in the adult mouse brain and spinal cord (Heinrich et al., 2014; Niu et al., 2013 Niu et al., , 2015 Su et al., 2014) . As a direct downstream target of SOX2, we asked whether TLX plays a role during this in vivo reprogramming process. We conditionally deleted the Tlx gene in astrocytes of mutant mice harboring floxed Tlx alleles (Tlx flox/flox ) and a Cre-transgene controlled by the human GFAP promoter (pGFAP-Cre). SOX2-expressing lentivirus was injected into the striatum of adult control (Tlx flox/flox ) or Tlx-deleted (pGFAP-Cre;Tlx flox/flox ) mice. DCX + neuroblasts were quantified surrounding the virus-injected striatal regions at 5 weeks post virus injection (wpi).
In contrast to control mice, the deletion of Tlx in astrocytes significantly decreased the detection of SOX2-induced DCX + cells in the adult striatum ( Figures 6A and 6B). Because of its essential role in maintaining adult neurogenesis (Liu et al., 2008; Niu et al., 2011; Shi et al., 2004; Zhang et al., 2008) , we also examined whether TLX itself is sufficient to induce DCX + cells. Adult wild-type mice were stereotactically injected with lentivirus expressing transcription factors or a control GFP under the GFAP promoter. Immunohistochemistry was performed at 5 wpi. Very interestingly, DCX + neuroblasts were specifically observed in striatal regions with ectopic TLX but not ASCL1 or GFP ( Figures 6C and 6D ). Nevertheless, the total number of DCX + cells induced by TLX was significantly fewer than SOX2 alone, and their morphology was also very primitive, suggesting that additional factor(s) are required for robust in vivo reprogramming. Of note, the inclusion of TLX failed to enhance SOX2-induced adult neurogenesis ( Figure 6C ), which is consistent with our finding that TLX functions downstream of SOX2. 
DISCUSSION
Although discovered more than two decades ago, the transcriptional regulation of Tlx in NSCs remains unclear (Yu et al., 1994) . Numerous microRNAs such as let-7b and miR-137 have been identified as potential regulators of NSC proliferation, and a subset of these, miR-9 and let7d, have been directly implicated in the regulation of TLX expression (Sun et al., 2011; Zhao et al., 2009 Zhao et al., , 2010 . Similarly, interleukin-1 beta (IL-1b) has been shown to repress Tlx expression in neural precursor cells, differentiating newborn neurons, mature neurons, and astrocytes (Green and Nolan, 2012; Koo and Duman, 2008) . However, the spatiotemporal mechanism that underlies Tlx transcription is undefined. In this study, we systematically examined the promoter and enhancer activity regulating Tlx expression in vivo and established genetic interactions between Tlx and two critical transcription factors, SOX2 and MYT1.
Comparative genomic analyses have proven to be a useful tool for identifying highly conserved regulatory elements that direct gene expression in a cell-or tissue-specific manner. Here, we identified two active regions, Enh1 and Enh2, upstream of the Tlx transcription start site that are sufficient to drive the expression of a reporter gene at E13.5. Importantly, these two enhancers were not previously identified as SOX2-binding regions in cell culture (Shimozaki et al., 2012) , which indicates the mechanisms regulating physiological Tlx expression might be significantly different from in vitro models. The systematic analysis of a transcriptional enhancer we termed Enh1 led to the identification of Enh1.1, a 582-bp cis-regulatory region active in the developing forebrain, retina, and other regions of the CNS. We subdivided the sequence of this putative enhancer to identify the highly conserved 120-bp cis-element Enh1.1.3. This element is preferentially active in TLX + cells in the SVZ of LV and is sufficient to drive reporter gene expression. In contrast to NSCs, other populations of cells in the SVZ did not exhibit Enh1.1.3 activity, which highlights the transcriptional specificity of this element. In addition, a second subregion of Enh1, Enh1.1.6, moderately activated reporter expression, potentially indicating that multiple redundant transcription factor binding sites exist within the Tlx enhancer. Four potential transcription factor binding sites were identified and investigated by site-directed mutagenesis based on their known functions and expression patterns (Avilion et al., 2003; Bellefroid et al., 1996; Graham et al., 2003; Pevny and Nicolis, 2010; Shi et al., 2008; Shimozaki et al., 2012) . The individual deletion of SOX2-binding sites only moderately affected Enh1.1.3 activity; however, the deletion of both sites severely abolished reporter expression. This functional redundancy might explain why the deletion of these two binding sites did not affect the activity of Enh1.1, which contains at least five SOX2-binding motifs. The deletion of a ChIP-validated MYT1-binding site repressed Enh1.1.3 activity, indicating the mechanism underlying Tlx expression is complex and involves multiple factors. These observations were validated by EMSA binding assays and in vivo ChIP assays. Further, Sox2 knockdown dramatically reduced Enh1.1 and Enh1.1.3 activity and significantly reduced TLX expression in vivo. Myt1 knockdown affected only Enh1.1.3 activity and moderately repressed in vivo TLX expression. This suggests a specific MYT1-Enh1.1.3 interaction that finetunes the expression of Tlx in NSCs. As a recently identified subunit of the lysine-specific demethylase 1 complex, a corepressor of Tlx, MYT1 might exert unique control over the onset of neurogenesis and neural differentiation in adult NSCs (Armstrong et al., 1995 Kim et al., 1997; Matsushita et al., 2014) .
Collectively, these data demonstrate that SOX2 and MYT1 regulate the spatiotemporal expression of Tlx in NSCs during postnatal development. The ectopic expression of SOX2, a transcription factor with well-defined roles in stem cell pluripotency and transcriptional regulation (Avilion et al., 2003; Catena et al., 2004; Graham et al., 2003; Lorthongpanich et al., 2008; Masui et al., 2007; Pevny and Nicolis, 2010; Rossant, 2004; Sarkar and Hochedlinger, 2013; Shimozaki et al., 2012; Suh et al., 2007) , was recently shown to reprogram reactive glia into neural progenitors and neurons in the adult mouse brain and spinal cord (Niu et al., 2013 (Niu et al., , 2015 Su et al., 2014) . Our current data further demonstrate that SOX2-regulated Tlx expression is required for this in vivo reprogramming process. These findings provide new insights into molecular mechanisms that govern NSC behavior and fate reprogramming.
EXPERIMENTAL PROCEDURES Animals
Wild-type C57BL/6 and ICR mice were obtained from The Jackson Laboratory and Harlan Laboratory, respectively. The generation of Tlx flox/flox mice was previously described (Zhang et al., 2008) . The transgenic pGFAP-Cre mice were created by the laboratory of Albee Messing (Zhuo et al., 2001 ) and purchased from The Jackson laboratory (stock number 004600). All mice were housed under a 12-hr light-dark cycle with ad libitum access to food and water in a controlled animal facility. All experimental protocols were approved by the Institutional Animal Care and Use Committee at The University of Texas Southwestern Medical Center.
Bioinformatics
The UCSC genome browser was used to retrieve sequences and annotations for the mouse Tlx gene and its cross-species homologs. Transcription factor binding sites in E1.1.3 were identified using the MatInspector application within the Genomatix Suite.
DNA Constructs and Site-Directed Mutagenesis
Assays for the activity of candidate Tlx cis-elements were performed using a human b-globin promoter plasmid carrying either a LacZ or GFP reporter. Evolutionarily conserved noncoding and coding subregions of the Tlx locus were PCR amplified and cloned to generate DNA constructs. Two constructs, CAG-GFP and CAGtdTomato, were used as transfection controls. A plasmid carrying the full-length mouse Myt1 cDNA was obtained from Addgene (plasmid 22713) and subcloned into a pCMX vector to generate a Myt1 construct with an amino terminus HA-tag for overexpression in knockdown studies. A PCR-based site-directed mutagenesis method was used to generate mutant enhancer constructs. Briefly, mutations were introduced by PCR using a set of primers with either a deletion or point mutation in the targeted binding site and then validated by DNA sequencing.
In Vivo DNA Electroporation
Mouse P0 forebrain DNA electroporation was performed essentially as previously described (Boutin et al., 2008) . Briefly, a 2-ml mixture of plasmid DNA and fast green FCF dye (4 mg/ml and 2 mg/ml final concentrations, respectively) was directly injected into the LVs of the P0 mouse forebrain using a glass micropipette. Five electric pulses (88 V, 50-ms duration, 950-ms intervals) were applied through the head with a CUY21 electroporator (Nepagene).
Immunohistochemistry
Mice were sacrificed, perfused with PBS, and then perfused by ice-cold 4% paraformaldehyde (PFA) in PBS. Brains were dissected and postfixed overnight with 4% PFA at 4 C followed by cryoprotection in a 30% sucrose solution overnight. Frozen brains were sectioned at 40 mm with a sliding microtome (Leica Microsystems). Free-floating sections were washed three times with PBS and blocked for 1 hr at room temperature (3% BSA and 0.2% Triton X-100 in PBS). The sections were immunostained overnight at 4 C with anti-SOX2 antibody (SC17320, goat, 1:500, Santa Cruz) diluted in blocking solution. After three rinses with wash buffer (0.2% Triton X-100 in PBS), the sections were incubated with Alexa-Fluor-594-conjugated secondary antibody (Jackson ImmunoResearch) in blocking solution for 2 hr at room temperature. Nuclei were stained with Hoechst 33342 (1 mg/ml, Sigma). Images were obtained on a Zeiss LSM510 confocal microscope. A Cell Counter software plugin for ImageJ was used to count cells. A representative image is shown from at least three similar images.
EMSA
Complementary single-stranded oligonucleotides were designed to mimic the Enh1. .0], 0.1% Triton X-100, EDTA-free complete protease inhibitor) and immunoprecipitated with anti-SOX2 (AB5603, rabbit, 5 mg, Millipore), anti-MYT1 (HPA006303, rabbit, 5 mg, Sigma), or anti-IgG (PP64, rabbit, 5 mg, Millipore) at 4 C for 14 hr. Protein G magnetic Dynabeads (100 ml, Life Technologies) were used to isolate immunoprecipitated chromatin at 4 C for 2 hr. The immunoprecipitated fraction was washed twice with immunoprecipitation buffer, twice with wash buffer (100 mM Tris-HCl [pH 9.0], 500 mM LiCl, 1% IGEPAL CA-630, 1% deoxycholic acid, and EDTA-free complete protease inhibitor) and one time with high salt wash buffer (wash buffer containing 150 mM NaCl). Chromatin was eluted in 100 ml elution buffer (1% SDS, 50 mM sodium bicarbonate) at 25 C for 30 min with shaking. Eluted chromatin was treated with 1 ml RNase A (10 mg/ml) and 2 ml Proteinase K (40 mg/ml) at 37 C for 1 hr, and then then crosslinking was reversed with NaCl (333 mM final concentration) at 67 C for 14 hr. Immunoprecipitated DNA was purified using the QIAquick PCR Purification Kit (QIAGEN) according to the manufacturer's specifications. Quantitative real-time PCR was performed to determine the foldenrichment of SOX2 and MYT1 immunoprecitated DNA relative to background in IgG-treated samples (primer sequences listed in Table S2 ).
shRNA-Mediated SOX2 and MYT1 Knockdown
Mouse P0 forebrains were transfected with Sox2-and Myt1-specific shRNAs or scrambled control (OriGene). All shRNAs were subcloned into the Superscript-GFP vector (shRNA sequences listed in Table S3 ).
Virus Generation and Stereotactic Injections
The lentiviral vectors GFAP-GFP, GFAP-Sox2, GFAP-GFP-T2A-Tlx, and GFAP-Ascl1 were generated as previously described (Niu et al., 2013) . Under the guidance of a stereotactic apparatus (Stoelting), a total volume of 2 ml purified virus, each with a titer of 0.5-1 3 10 9 colony-forming units per 1 ml, was injected into the striatum of adult mice. The injection coordinates follow: +1.0 mm (anterior-posterior), ±2 mm (medial-lateral), and À3.0 mm (dorsal-ventral from the skull).
Statistical Analysis
Data are presented as mean ± SEM. Statistical analysis was performed by a two-tailed unpaired Student's t test. Any p value < 0.05 was considered significant. 
SUPPLEMENTAL INFORMATION
